TRCT
NAUT icon

Tower Research Capital (TRC)’s Nautilus Biotechnolgy NAUT Stock Holding History

Tower Research Capital (TRC)’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.29K Buy
+2,827
New +$7.46K ﹤0.01% 4286
2026
Q1 		– Sell
-5
Closed -$10 – 5401
2025
Q4 		$10 Sell
5
-5,598
-100% -$9.18K ﹤0.01% 5108
2025
Q3 		$4.73K Sell
5,603
-15,978
-74% -$11.7K ﹤0.01% 4301
2025
Q2 		$15.6K Buy
21,581
+10,827
+101% +$8.13K ﹤0.01% 3805
2025
Q1 		$9.26K Sell
10,754
-2,477
-19% -$3.68K ﹤0.01% 3802
2024
Q4 		$22.2K Buy
13,231
+9,699
+275% +$23.2K ﹤0.01% 3105
2024
Q3 		$10.1K Sell
3,532
-6,806
-66% -$17.6K ﹤0.01% 3807
2024
Q2 		$24.2K Buy
10,338
+6,432
+165% +$16.8K ﹤0.01% 3652
2024
Q1 		$11.5K Sell
3,906
-691
-15% -$1.96K ﹤0.01% 3559
2023
Q4 		$13.7K Buy
4,597
+89
+2% +$255 ﹤0.01% 3938
2023
Q3 		$14.2K Buy
4,508
+2,291
+103% +$7.46K ﹤0.01% 3700
2023
Q2 		$8.58K Sell
2,217
-2,516
-53% -$7.25K ﹤0.01% 4409
2023
Q1 		$13K Sell
4,733
-1,079
-19% -$2.26K ﹤0.01% 3988
2022
Q4 		$10K Sell
5,812
-423
-7% -$817 ﹤0.01% 4037
2022
Q3 		$13K Sell
6,235
-13,251
-68% -$33.3K ﹤0.01% 4275
2022
Q2 		$52K Buy
19,486
+17,066
+705% +$63.5K ﹤0.01% 2842
2022
Q1 		$11K Sell
2,420
-150
-6% -$616 ﹤0.01% 4192
2021
Q4 		$14K Buy
2,570
+1,570
+157% +$8.4K ﹤0.01% 4089
2021
Q3 		$6K Buy
+1,000
New +$7.97K ﹤0.01% 4766
2021
Q2 		– Sell
-15
Closed – – 5711
2021
Q1 		$0 Buy
+15
New +$208 ﹤0.01% 5602

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Tower Research Capital (TRC)'s NAUT Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 2,827 shares worth $5.29K. The stake represents ﹤0.01% of the portfolio and ranks #4286 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in NAUT as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in NAUT in Q1 2021 and has held it in 20 quarters since. The position peaked at $52K in Q2 2022. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Tower Research Capital (TRC) held 2,827 shares of Nautilus Biotechnolgy worth $5.29K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Tower Research Capital (TRC) position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4286 holding.
  • Tower Research Capital (TRC) first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Nautilus Biotechnolgy position peaked at $52K in Q2 2022.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.